125 related articles for article (PubMed ID: 11106324)
41. Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy.
Schmidt H; Sorensen BS; Fode K; Nexo E; von der Maase H
Melanoma Res; 2005 Oct; 15(5):409-16. PubMed ID: 16179868
[TBL] [Abstract][Full Text] [Related]
42. Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells.
Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Schenk F; Franzke A; Atzpodien J; Buer J
Melanoma Res; 2000 Aug; 10(4):355-62. PubMed ID: 10985670
[TBL] [Abstract][Full Text] [Related]
43. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma.
Ghossein RA; Coit D; Brennan M; Zhang ZF; Wang Y; Bhattacharya S; Houghton A; Rosai J
Clin Cancer Res; 1998 Feb; 4(2):419-28. PubMed ID: 9516931
[TBL] [Abstract][Full Text] [Related]
45. Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma.
Hochberg M; Lotem M; Gimon Z; Shiloni E; Enk CD
Br J Dermatol; 2002 Feb; 146(2):244-9. PubMed ID: 11903234
[TBL] [Abstract][Full Text] [Related]
46. Molecular detection of tyrosinase transcripts in peripheral blood from patients with malignant melanoma: correlation of PCR sensitivity threshold with clinical and pathologic disease characteristics.
Mitropapas G; Nezos A; Halapas A; Pissimissis N; Lembessis P; Sourla A; Vassilopoulos P; Koutsilieris M
Clin Chem Lab Med; 2006; 44(12):1403-9. PubMed ID: 17163814
[TBL] [Abstract][Full Text] [Related]
47. Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.
Hoshimoto S; Faries MB; Morton DL; Shingai T; Kuo C; Wang HJ; Elashoff R; Mozzillo N; Kelley MC; Thompson JF; Lee JE; Hoon DS
Ann Surg; 2012 Feb; 255(2):357-62. PubMed ID: 22202581
[TBL] [Abstract][Full Text] [Related]
48. Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients.
Koyanagi K; Mori T; O'Day SJ; Martinez SR; Wang HJ; Hoon DS
Cancer Res; 2006 Jun; 66(12):6111-7. PubMed ID: 16778184
[TBL] [Abstract][Full Text] [Related]
49. Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood.
de Vries TJ; Fourkour A; Punt CJ; Diepstra H; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(6):1066-70. PubMed ID: 10576666
[TBL] [Abstract][Full Text] [Related]
50. Melanoma-associated antigens as messenger RNA detection markers for melanoma.
Sarantou T; Chi DD; Garrison DA; Conrad AJ; Schmid P; Morton DL; Hoon DS
Cancer Res; 1997 Apr; 57(7):1371-6. PubMed ID: 9102226
[TBL] [Abstract][Full Text] [Related]
51. Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
Carrillo E; Marchal JA; Prados J; Melguizo C; Vélez C; Arena N; Alvarez L; Serrano S; Aránega A
Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1247-52. PubMed ID: 9874512
[TBL] [Abstract][Full Text] [Related]
52. RT-PCR detection of tyrosinase, gp100, MART1/Melan-A, and TRP-2 gene transcripts in peripheral blood of melanoma patients.
Samija M; Juretić A; Solarić M; Samija I; Bingulac-Popović J; Grahovac B; Stanec M; Oresić V
Croat Med J; 2001 Aug; 42(4):478-83. PubMed ID: 11471202
[TBL] [Abstract][Full Text] [Related]
53. Establishment of a screening system for chemicals that upregulate a melanoma antigen, Melan-A/MART-1.
Song HZ; Kono M; Tomita Y
Tohoku J Exp Med; 2009 Mar; 217(3):231-7. PubMed ID: 19282659
[TBL] [Abstract][Full Text] [Related]
54. Quantitative real-time RT-PCR in sentinel lymph nodes from melanoma patients. Detection of melanocytic mRNA predicts disease-free survival.
Riber-Hansen R; Abrahamsen HN; Sorensen BS; Hamilton-Dutoit SJ; Steiniche T
APMIS; 2008 Mar; 116(3):199-205. PubMed ID: 18377585
[TBL] [Abstract][Full Text] [Related]
55. [Detection of tumor cells in peripheral blood of patients with gastric cancer using mRNA of MAGE genes as markers].
Wang WX; Li YB; Xie XL; Shu XL; Ouyang XH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):611-4. PubMed ID: 19921576
[TBL] [Abstract][Full Text] [Related]
56. Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.
Hilari JM; Mangas C; Xi L; Paradelo C; Ferrándiz C; Hughes SJ; Yueh C; Altomare I; Gooding WE; Godfrey TE
Ann Surg Oncol; 2009 Jan; 16(1):177-85. PubMed ID: 18982394
[TBL] [Abstract][Full Text] [Related]
57. Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA.
Hofbauer GF; Dummer R; Laine E; Burg G
Arch Dermatol Res; 1998 Aug; 290(8):458-61. PubMed ID: 9763311
[No Abstract] [Full Text] [Related]
58. Expression of melanoma inhibitory activity in melanoma and nonmelanoma tissue specimens.
Perez RP; Zhang P; Bosserhoff AK; Buettner R; Abu-Hadid M
Hum Pathol; 2000 Nov; 31(11):1381-8. PubMed ID: 11112213
[TBL] [Abstract][Full Text] [Related]
59. Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients.
Abrahamsen HN; Steiniche T; Nexo E; Hamilton-Dutoit SJ; Sorensen BS
J Mol Diagn; 2003 Feb; 5(1):34-41. PubMed ID: 12552078
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients.
Jung FA; Buzaid AC; Ross MI; Woods KV; Lee JJ; Albitar M; Grimm EA
J Clin Oncol; 1997 Aug; 15(8):2826-31. PubMed ID: 9256125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
